NSC |
Compound |
Enrichment |
Correlation |
NSC 741459 |
(11aS)-8-(3-[(11aS)-2,2-difluoro-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropoxy)-2,2-difluoro-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4 |
0.012942183459279 |
0.092154717 |
NSC 748902 |
[(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] |
0.012942183459279 |
0.43563354 |
NSC 750050 |
Null |
0.012942183459279 |
0.54532752 |
NSC 751605 |
(E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide |
0.012942183459279 |
0.33474629 |
NSC 752278 |
2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt |
0.012942183459279 |
0.018019387 |
NSC 753377 |
3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine |
0.012942183459279 |
0.44930069 |
NSC 761832 |
(Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one |
0.012942183459279 |
0.1733526 |
NSC 762908 |
2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one |
0.012942183459279 |
0.59739125 |
NSC 623626 |
Null |
0.0133012546828912 |
0.14014906 |
NSC 681135 |
Null |
0.0133012546828912 |
0.14461501 |